ET‐1 has been found to increase ET‐1 levels in pneumonia, pulmonary hypertension, interstitial fibrosis and acute respiratory distress syndrome in humans (Bouallegue et al. Here, EDN1 is linked to susceptibility to pneumonia measurement.